The small GTPase Rap1, which is activated by a large variety of stimuli, functions in the control of integrinmediated cell adhesion. Here we show that in human megakaryocytes and several other commonly used hematopoietic cell lines such as K562, Jurkat, and THP-1, stress induced by gentle tumbling of the samples resulted in rapid and strong activation of Rap1. This turbulence-induced activation could not be blocked by inhibitors previously shown to affect Rap1 activation in human platelets, such as the intracellular calcium chelator BAPTA-AM (1,2-bis(2-aminophenoxy)ethane-N,N,N,N-tetraacetic acid) and various protein kinase C inhibitors. Also inhibition of actin cytoskeleton dynamics did not influence this activation of Rap1, suggesting that this activation is mediated by cell surface receptors. Human platelets, however, were refractory to turbulence-induced activation of Rap1. To determine the consequences of Rap1 activation we measured adhesion of megakaryocytes to fibrinogen, which is mediated by the integrin ␣ IIb  3 , in the presence of inhibitors of Rap1 signaling. Introduction of both Rap1GAP and RalGDS-RBD in the megakaryoblastic cell line DAMI strongly reduced basal adhesion to immobilized fibrinogen. This inhibition was partially rescued by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate but not by ␣-thrombin. From these results we conclude that in megakaryocytes turbulence induces Rap1 activation that controls ␣ IIb  3 -mediated cell adhesion.The small GTPase Rap1 is a molecular switch that cycles between an inactive GDP and active GTP-bound conformation. The protein can be activated by a plethora of stimuli (1-6), indicating that Rap1 activation is a common event in signaling. In general this activation is mediated by second messengers such as cAMP, calcium ions, and diacylglycerol; and a number of guanine nucleotide exchange factors have been identified to mediate this activation (7). In human platelets, Rap1 is abundantly expressed and is rapidly activated by a large variety of agonists including ␣-thrombin, thromboxane A 2 , epinephrine, platelet-activating factor, ADP, and the phorbol ester TPA 1 (1). At least two different signaling pathways are involved in this activation, one mediated by G q , phospholipase C, and calcium and one mediated by protein kinase C (PKC) and phosphatidylinositol 3-kinase (PI3K) (1, 8 -10). In platelets, Rap1 activation is rapidly inhibited by agents that increase the intracellular cAMP concentration, like for instance prostaglandin I 2 (1). Activation of Rap1 is prior to platelet activation, suggesting a key role of Rap1 in this process. After platelet activation Rap1 relocalizes to the actin cytoskeleton (8,11,12). In the control of Rap1 in platelets, RapGAP, which can interact with the active ␣ subunit of the heterotrimeric G-protein G z , plays a role as well (13).In a variety of cell lines, Rap1 was found to be involved in the regulation of integrin-mediated cell adhesion. Rap1 controls T-cell receptor-, CD31-, and CD98-induced activation of ␣ L  2 (14 ...